Press Release - Company Data

SuperGen, Inc. Changes Name to Astex Pharmaceuticals, Inc., Announces New Stock Ticker Symbol and New Website
Posted 2011-09-11 23:50NAI Editing
announced that it has officially begun operating under the name Astex Pharmaceuticals, Inc.

SuperGen, Inc. to Change Name and Stock Ticker Symbol
Posted 2011-09-02 00:03NAI Editing
, a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced it anticipates that it will begin operating under the name Astex Pharmaceuticals, Inc.

SuperGen Reports 2011 Second Quarter Financial Results
Posted 2011-08-03 00:53NAI Editing
today reported financial results for the second quarter ended June 30, 2011.

SuperGen to Present at Future Leaders in the Biotech Industry on April 15th
Posted 2011-04-08 07:26NAI Editing
,a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J.

SuperGen Announces Presentation of SGI-110 Preclinical Data at American Society of Hematology
Posted 2010-12-03 08:25NAI500 Admin
today announced that a summary of preclinical efficacy, safety, and pharmacokinetics data of SGI-110 will be presented at the American Society of Hematology in Orlando on Saturday, December 4, 2010 at

SuperGen to Present at BIO CEO & Investor Conference on February 8th
Posted 2010-02-01 12:10NAI500 Admin
a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J.

SuperGen to Present at Biotech Showcase 2010 on January 12th
Posted 2010-01-05 17:19NAI500 Admin
a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J.

SuperGen Data Presentations at American Society of Hematology (ASH) Annual Meeting
Posted 2009-12-01 11:04NASDAQ_SUPG
a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of two abstracts for poster presentations on December 6, 2009 at the 51st

SuperGen to Present at Lazard Healthcare Conference on November 18, 2009
Posted 2009-11-11 13:23NAI500 Admin
, a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J.

SuperGen Reports 2009 Third Quarter Financial Results
Posted 2009-10-26 16:34NAI500 Admin
today reported financial results for the third quarter and nine months ended September 30, 2009.